Metformin to reduce weight gain from antipsychotic medicines
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This trial tests whether metformin can help adults with intellectual disability who gained weight from long-term antipsychotic medicines. If you qualify, you may be assigned metformin to improve weight and related health measures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an outpatient (not currently hospitalized) and generally stable
- You’re age 16 to 65 and have an intellectual disability diagnosis
- You’ve been taking an antipsychotic at a stable dose for at least 3 months
- Your weight is in a higher range (BMI 30+), or BMI 27+ with a related problem (like high blood pressure or sleep apnea), or BMI 25+ if you gained 5%+ weight after starting the antipsychotic
- You must have no major health issues that make metformin unsafe (for example serious heart/lung/kidney problems, certain acid build-ups, or major recent events)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of a common antipsychotic medication affects how the brain responds to insulin, which could help explain weight gain and metabolic side effects. Healthy young adults will receive either the antipsychotic or a placebo, then have their brain activity measured with an MRI.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
This study compares two medicines, dapagliflozin and metformin, to see which is better at helping people who have gained weight from antipsychotic medications. Both are already approved for diabetes but may also help with weight loss.
This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
Hear when a new Intellectual Disability trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.